Table 1.
Demographics and treatment response of 33 dogs with chronic enteropathy and known long-term clinical outcome data.
| C. Difficile-Negative (n = 25) | C. Difficile-Positive (n = 8) | p-Value | |
|---|---|---|---|
| demographic data | |||
| Age in years (median (range)) | 5 (0.5–12) | 5 (1–10) | 0.97 |
| Male (n, %); female (n, %) | Male (13, 52%); female (12, 48%) | Male (5, 63%); female (3, 37%) | 0.60 |
| Weight (kg) (median) | 10.2 | 15.5 | 0.72 |
| CIBDAI (median (range)) | 7 (2–12) | 7.5 (5–14) | 0.68 |
| treatment response in % of dogs (x/y) | |||
| FRE | 63% (17/25) | 75% (6/8) | 0.70 |
| SRE | 19% (5/25) | 12.5% (1/8) | 0.63 |
| ARE | 4% (1/25) | 12.5% (1/8) | 0.38 |
| Non-responders | 7% (2/25) | - | 0.41 |
| Total | 100% (25/25) | 100% (8/8) | |
CIBDAI = canine inflammatory bowel disease activity index; FRE = food-responsive enteropathy; SRE = steroid-responsive enteropathy; ARE = antibiotic-responsive enteropathy.